Marc Rodger

26.4k total citations · 6 hit papers
271 papers, 14.6k citations indexed

About

Marc Rodger is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Marc Rodger has authored 271 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Internal Medicine, 124 papers in Cardiology and Cardiovascular Medicine and 96 papers in Hematology. Recurrent topics in Marc Rodger's work include Venous Thromboembolism Diagnosis and Management (196 papers), Blood Coagulation and Thrombosis Mechanisms (93 papers) and Atrial Fibrillation Management and Outcomes (91 papers). Marc Rodger is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (196 papers), Blood Coagulation and Thrombosis Mechanisms (93 papers) and Atrial Fibrillation Management and Outcomes (91 papers). Marc Rodger collaborates with scholars based in Canada, United States and France. Marc Rodger's co-authors include Philip S. Wells, David R. Anderson, Grégoire Le Gal, Susan R. Kahn, Michael J. Kovacs, Marc Carrier, George Kovács, Melissa Forgie, Clive Kearon and Jonathan Dreyer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marc Rodger

254 papers receiving 14.0k citations

Hit Papers

Evaluation of D-Dimer in the Diagnosis of Suspected Deep-... 2001 2026 2009 2017 2003 2001 2008 2003 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
    2003 990 citations Philip S. Wells, David R. Anderson et al. profile →
  2. Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer
    2001 934 citations Philip S. Wells, David R. Anderson et al. Annals of Internal Medicine profile →
  3. A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
    2008 717 citations Dean Fergusson, Marc Rodger et al. profile →
  4. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
    2003 544 citations Clive Kearon, Michael J. Kovacs et al. profile →
  5. Venous thromboembolism
    2021 378 citations Faizan Khan, Tobias Tritschler et al. profile →
  6. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
    2018 335 citations Marc Rodger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Rodger Canada 62 9.9k 6.6k 3.9k 3.3k 1.7k 271 14.6k
Jeffrey S. Ginsberg Canada 67 12.2k 1.2× 9.4k 1.4× 5.1k 1.3× 5.4k 1.6× 2.1k 1.2× 208 16.5k
Susan R. Kahn Canada 70 20.3k 2.1× 11.5k 1.7× 4.2k 1.1× 10.0k 3.1× 5.4k 3.1× 330 25.8k
Marc Carrier Canada 51 8.1k 0.8× 5.6k 0.9× 1.8k 0.5× 2.3k 0.7× 2.5k 1.4× 388 11.0k
Grégoire Le Gal France 60 10.2k 1.0× 6.3k 0.9× 2.1k 0.5× 3.2k 1.0× 2.0k 1.2× 409 13.7k
Philip S. Wells Canada 63 14.9k 1.5× 10.4k 1.6× 3.2k 0.8× 5.6k 1.7× 3.2k 1.8× 299 19.7k
Charles Marc Samama France 50 6.7k 0.7× 5.8k 0.9× 1.4k 0.4× 4.3k 1.3× 840 0.5× 197 12.2k
Richard H. White United States 61 8.5k 0.9× 5.5k 0.8× 2.6k 0.7× 4.0k 1.2× 2.0k 1.2× 242 15.9k
Walter Ageno Italy 67 13.7k 1.4× 11.4k 1.7× 3.6k 0.9× 4.0k 1.2× 1.9k 1.1× 557 20.5k
Sam Schulman Canada 69 21.5k 2.2× 21.5k 3.3× 7.7k 2.0× 7.1k 2.2× 2.4k 1.4× 501 34.5k
Menno V. Huisman Netherlands 76 20.0k 2.0× 15.5k 2.3× 3.2k 0.8× 5.8k 1.8× 3.5k 2.0× 469 29.6k

Countries citing papers authored by Marc Rodger

Since Specialization
Citations

This map shows the geographic impact of Marc Rodger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rodger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rodger more than expected).

Fields of papers citing papers by Marc Rodger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rodger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rodger. The network helps show where Marc Rodger may publish in the future.

Co-authorship network of co-authors of Marc Rodger

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rodger. A scholar is included among the top collaborators of Marc Rodger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rodger. Marc Rodger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodger, Marc, Michael J. Kovacs, Grégoire Le Gal, et al.. (2025). Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. Journal of Thrombosis and Haemostasis. 23(4). 1379–1392.
2.
Righini, Marc, Sam Schulman, Venkatesh Thiruganasambandamoorthy, et al.. (2025). Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. Journal of Thrombosis and Haemostasis. 23(10). 3239–3250.
3.
King, James A., Jenny Godley, Deborah Siegal, et al.. (2024). Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. PubMed. 1(1). 100004–100004. 1 indexed citations
4.
Rodger, Marc, Waleed Ghanima, Michael J. Kovacs, et al.. (2023). Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study. Thrombosis and Haemostasis. 123(7). 692–699. 2 indexed citations
5.
Khan, Faizan, Doug Coyle, Kednapa Thavorn, et al.. (2023). Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Annals of Internal Medicine. 176(7). 949–960. 6 indexed citations
6.
Guo, Yanfang, Daniel J. Corsi, Ruth Rennicks White, et al.. (2022). Folic Acid Supplementation in Early Pregnancy, Homocysteine Concentration, and Risk of Gestational Diabetes Mellitus. Journal of Obstetrics and Gynaecology Canada. 44(2). 196–199. 3 indexed citations
7.
Taljaard, Monica, Amanda J MacFarlane, Laura Gaudet, et al.. (2020). The determinants of maternal homocysteine in pregnancy: findings from the Ottawa and Kingston Birth Cohort. Public Health Nutrition. 23(17). 3170–3180. 6 indexed citations
8.
9.
Dadelszen, Peter von, Laura A. Magee, Samantha J. Benton, et al.. (2018). Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial. Pregnancy Hypertension. 13. 121–126. 6 indexed citations
10.
Skeith, Leslie, et al.. (2017). Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies. Thrombosis Research. 157. 23–28. 36 indexed citations
11.
Carrier, Marc, Judy Kovacs, Marc Rodger, et al.. (2017). Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode. Journal of Thrombosis and Haemostasis. 15(10). 1977–1980. 2 indexed citations
12.
Castellucci, Lana A., Kerstin Hogg, Cynthia Wu, et al.. (2017). Comparison of Bleeding Risk between Rivaroxaban and Apixaban: a Pilot Feasibility Study. Blood. 130. 1108–1108. 2 indexed citations
13.
Castellucci, Lana A., et al.. (2017). Comparing Medication Adherence Tools for the Direct Oral Anticoagulants Rivaroxaban and Apixaban. Blood. 130. 3713–3713. 1 indexed citations
14.
Lazo‐Langner, Alejandro, Susan R. Kahn, Philip S. Wells, et al.. (2016). Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study. Blood. 128(22). 417–417. 3 indexed citations
15.
Ageno, Walter, Benilde Cosmi, Michael J. Kovacs, et al.. (2013). Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis. Thrombosis and Haemostasis. 111(1). 172–179. 79 indexed citations
16.
Qiu, Qing, Michael D. Bell, Xiaoyin Lu, et al.. (2012). Significance of IGFBP-4 in the Development of Fetal Growth Restriction. The Journal of Clinical Endocrinology & Metabolism. 97(8). E1429–E1439. 28 indexed citations
17.
Gong, Inna Y., Ute I. Schwarz, Natalie Crown, et al.. (2011). Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation. PLoS ONE. 6(11). e27808–e27808. 62 indexed citations
18.
Lazo‐Langner, Alejandro & Marc Rodger. (2009). Overview of Current Venous Thromboembolism Protocols in Hip Reconstruction. Orthopedic Clinics of North America. 40(3). 427–436. 2 indexed citations
19.
Rodger, Marc, Melissa A. Forgie, Nicole Langlois, et al.. (2003). The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism. Thrombosis and Haemostasis. 90(11). 829–834. 16 indexed citations
20.
Rodger, Marc, Marc Carrier, Gwynne Jones, et al.. (2000). Diagnostic Value of Arterial Blood Gas Measurement in Suspected Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 162(6). 2105–2108. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey S. Ginsberg Breakdown of academic impact, for papers by Susan R. Kahn Breakdown of academic impact, for papers by Marc Carrier Breakdown of academic impact, for papers by Grégoire Le Gal Breakdown of academic impact, for papers by Philip S. Wells Breakdown of academic impact, for papers by Charles Marc Samama Breakdown of academic impact, for papers by Richard H. White Breakdown of academic impact, for papers by Walter Ageno Breakdown of academic impact, for papers by Sam Schulman Breakdown of academic impact, for papers by Menno V. Huisman
Rankless by CCL
2026